285 related articles for article (PubMed ID: 11006045)
1. Endometrial carcinoma remaining after term pregnancy following conservative treatment with medroxyprogesterone acetate.
Mitsushita J; Toki T; Kato K; Fujii S; Konishi I
Gynecol Oncol; 2000 Oct; 79(1):129-32. PubMed ID: 11006045
[TBL] [Abstract][Full Text] [Related]
2. [Outcome analysis of conservative treatment of well-differentiated endometrial adenocarcinoma and severe atypical hyperplasia in young women].
Yu M; Shen K; Yang JX; Huang HF; Wu M; Pan LY; Lang JH; Lian LJ
Zhonghua Fu Chan Ke Za Zhi; 2006 Apr; 41(4):242-5. PubMed ID: 16759458
[TBL] [Abstract][Full Text] [Related]
3. Outcomes of conservative therapy for young women with early endometrial adenocarcinoma.
Mao Y; Wan X; Chen Y; Lv W; Xie X
Fertil Steril; 2010 Jan; 93(1):283-5. PubMed ID: 19962142
[TBL] [Abstract][Full Text] [Related]
4. Successful pregnancy after conservative surgery for stage IA endometrial cancer in a young woman.
Yasuda M; Terai Y; Sekijima T; Sasaki H; Yamashita Y; Kanemura M; Ohmichi M
Fertil Steril; 2009 Mar; 91(3):936.e13-5. PubMed ID: 19062001
[TBL] [Abstract][Full Text] [Related]
5. Outcome of fertility-preserving treatment in young women with endometrial carcinomas.
Niwa K; Tagami K; Lian Z; Onogi K; Mori H; Tamaya T
BJOG; 2005 Mar; 112(3):317-20. PubMed ID: 15713146
[TBL] [Abstract][Full Text] [Related]
6. Long-term conservative therapy for endometrial adenocarcinoma in young women.
Yahata T; Fujita K; Aoki Y; Tanaka K
Hum Reprod; 2006 Apr; 21(4):1070-5. PubMed ID: 16361282
[TBL] [Abstract][Full Text] [Related]
7. Hormonal therapy for the management of grade 1 endometrial adenocarcinoma: a literature review.
Ramirez PT; Frumovitz M; Bodurka DC; Sun CC; Levenback C
Gynecol Oncol; 2004 Oct; 95(1):133-8. PubMed ID: 15385122
[TBL] [Abstract][Full Text] [Related]
8. [Hormonal therapy for endometrial adenocarcinoma].
Susumu N; Aoki D; Suzuki N; Nozawa S
Gan To Kagaku Ryoho; 2001 Jul; 28(7):934-45. PubMed ID: 11478142
[TBL] [Abstract][Full Text] [Related]
9. [Conservative treatment of endometrial cancer as a way to preserve fertility. Five-year experience at Instituto Nacional de Perinatilogía Isidro Espinoza de los Reyes].
Arteaga Gómez AC; Castellanos Barroso G; Márquez Acosta G
Ginecol Obstet Mex; 2012 Jun; 80(6):394-9. PubMed ID: 22826967
[TBL] [Abstract][Full Text] [Related]
10. Epidermal growth factor receptor signaling enhanced by long-term medroxyprogesterone acetate treatment in endometrial carcinoma.
Zhao S; Chen X; Lu X; Yu Y; Feng Y
Gynecol Oncol; 2007 Apr; 105(1):45-54. PubMed ID: 17240435
[TBL] [Abstract][Full Text] [Related]
11. A patient with stage 1a endometrial carcinoma in whom a solitary recurrent lesion was detected in the external iliac lymph node after MPA therapy.
Takahashi N; Hirashima Y; Harashima S; Takekuma M; Kawaguchi R; Yamada Y; Ito I
Arch Gynecol Obstet; 2008 Oct; 278(4):365-7. PubMed ID: 18273628
[TBL] [Abstract][Full Text] [Related]
12. Sparing fertility in young patients with endometrial cancer.
Chiva L; Lapuente F; González-Cortijo L; Carballo N; García JF; Rojo A; Gonzalez-Martín A
Gynecol Oncol; 2008 Nov; 111(2 Suppl):S101-4. PubMed ID: 18804267
[TBL] [Abstract][Full Text] [Related]
13. [Endometrial adenocarcinoma in women 40 years old or younger by treatment with progestins: report of 6 cases and review of the literatures].
Wang HY; Shen L; Sun Z
Zhonghua Fu Chan Ke Za Zhi; 2006 Apr; 41(4):237-41. PubMed ID: 16759457
[TBL] [Abstract][Full Text] [Related]
14. [Young women with atypical endometrial hyperplasia or endometrial adenocarcinoma stage I: will conservative treatment allow pregnancy? Results of a French multicentric survey].
Le Digabel JF; Gariel C; Catala L; Dhainaut C; Madelenat P; Descamps P
Gynecol Obstet Fertil; 2006 Jan; 34(1):27-33. PubMed ID: 16406735
[TBL] [Abstract][Full Text] [Related]
15. Fertility-preserving treatment with progestin, and pathological criteria to predict responses, in young women with endometrial cancer.
Yamazawa K; Hirai M; Fujito A; Nishi H; Terauchi F; Ishikura H; Shozu M; Isaka K
Hum Reprod; 2007 Jul; 22(7):1953-8. PubMed ID: 17449880
[TBL] [Abstract][Full Text] [Related]
16. Ovarian metastasis in a nulliparous woman with endometrial adenocarcinoma failing conservative hormonal treatment.
Huang SY; Jung SM; Ng KK; Chang YC; Lai CH
Gynecol Oncol; 2005 May; 97(2):652-5. PubMed ID: 15863173
[TBL] [Abstract][Full Text] [Related]
17. Fertility sparing treatment of complex atypical hyperplasia and low grade endometrial cancer using oral progestin.
Simpson AN; Feigenberg T; Clarke BA; Gien LT; Ismiil N; Laframboise S; Massey C; Ferguson SE
Gynecol Oncol; 2014 May; 133(2):229-33. PubMed ID: 24561246
[TBL] [Abstract][Full Text] [Related]
18. Effectiveness of high-dose progestin and long-term outcomes in young women with early-stage, well-differentiated endometrioid adenocarcinoma of uterine endometrium.
Park H; Seok JM; Yoon BS; Seong SJ; Kim JY; Shim JY; Park CT
Arch Gynecol Obstet; 2012 Feb; 285(2):473-8. PubMed ID: 21706284
[TBL] [Abstract][Full Text] [Related]
19. Pregnancy outcome in patients with stage 1a endometrial adenocarcinoma, who conservatively treated with megestrol acetate.
Shirali E; Yarandi F; Eftekhar Z; Shojaei H; Khazaeipour Z
Arch Gynecol Obstet; 2012 Mar; 285(3):791-5. PubMed ID: 21805142
[TBL] [Abstract][Full Text] [Related]
20. Multicenter phase II study of fertility-sparing treatment with medroxyprogesterone acetate for endometrial carcinoma and atypical hyperplasia in young women.
Ushijima K; Yahata H; Yoshikawa H; Konishi I; Yasugi T; Saito T; Nakanishi T; Sasaki H; Saji F; Iwasaka T; Hatae M; Kodama S; Saito T; Terakawa N; Yaegashi N; Hiura M; Sakamoto A; Tsuda H; Fukunaga M; Kamura T
J Clin Oncol; 2007 Jul; 25(19):2798-803. PubMed ID: 17602085
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
